Lactulose-mannitol test: how to interpret results without guessing

Quick answer

The lactulose-mannitol test is a barrier function signal, not a standalone diagnosis. You drink two sugar molecules and a timed urine collection estimates how much of each crossed the intestinal barrier. Interpretation must include symptoms, medication context, inflammatory markers, and a differential diagnosis — an abnormal ratio alone never proves that "leaky gut" is causing your problems, and a normal ratio alone never rules out a functional bowel disorder. Gastroenterologists treat it as one of several permeability measurements, each with known limitations (Camilleri 2019).

What the test measures

You drink two sugars: mannitol (a small molecule, taken up through normal absorption pathways — it probes the villous absorptive surface) and lactulose (a large molecule that a healthy small intestine absorbs only minimally, so urinary recovery mainly reflects paracellular "leak" across the barrier). Urine is collected over a timed window — classically the first 2 to 6 hours — and a laboratory measures how much of each sugar was excreted.

Two numbers come out of this:

• Absolute excretion of each sugar. Low mannitol can signal reduced absorptive surface (for example, villous atrophy in celiac disease) independent of any leakiness. High lactulose can signal increased paracellular permeability.
• The lactulose-to-mannitol (L/M) ratio. Because the ratio is corrected for how fast each person absorbs and excretes, it is generally considered the more interpretable output — it reflects barrier behavior rather than kidney function or gut transit speed on their own.

The reason the ratio matters: anything that speeds gastric emptying or gut transit, or impairs renal clearance, moves both sugars together and distorts absolute values. The ratio cancels much of that noise out. This is also why laboratories report reference ranges specific to their own collection window and assay — you cannot compare your ratio from one lab to a threshold from a different protocol.

The most common interpretation error

People treat one abnormal value as proof that "leaky gut causes everything." That is the trap.

Better interpretation looks at pattern and ratio, and checks confounders before reading anything into the numbers. The most common ones:

• NSAIDs and alcohol — the classic candidates. But even NSAIDs are less reliable as a confounder than influencer content suggests: a 2026 randomized crossover trial in healthy volunteers found that indomethacin, a strong NSAID, failed to increase intestinal permeability at all in that cohort (Camilleri 2026). Acute NSAID effects in people with existing gut inflammation are a different story — context decides.
• Acute gastroenteritis — a recent infection can transiently raise permeability for weeks. Testing within a month of a bad stomach bug mostly measures the recovery process, not your baseline.
• Intense exercise — endurance exercise measurably raises gut permeability. Notably, a randomized controlled trial showed whey protein taken before exercise blunted that rise (Ulluwishewa 2024), which is one of the cleaner intervention signals in this literature — and also a reminder that yesterday's workout can move today's number.
• Sample timing errors — an incomplete urine collection makes the whole test uninterpretable.

Then correlate the result with the symptom timeline, and rule out celiac disease or inflammatory bowel disease when the picture suggests them. An elevated L/M ratio is a finding, not a disease name.

Pattern-based reading

Pattern A: higher lactulose with an altered (elevated) L/M ratio

May suggest increased paracellular permeability in context. In practice, this is the pattern most often over-read. Elevated ratios show up in IBS subgroups — one case-control study found that noninvasive barrier markers, including lactulose recovery, separated diarrhea-predominant IBS patients into two subtypes with different barrier behavior (Linsalata 2018) — but they also show up in acute illness, heavy training blocks, and after alcohol. You still need symptom correlation before acting on it.

Pattern B: low mannitol with variable lactulose

This pattern can suggest reduced absorptive surface and needs broader evaluation before you draw conclusions — celiac serology and, if indicated, duodenal biopsy come before any supplement protocol. Low mannitol recovery can also simply mean the urine window was missed.

Pattern C: near-normal values but high symptoms

Does not rule out functional bowel disorders, dysbiosis, motility issues, or visceral sensitivity. Permeability is one mechanism among many; the test measures only one of them. This is exactly why the test is only one input.

What to pair with this test

• Celiac screening (tTG-IgA plus total IgA) when appropriate — untreated celiac is the clearest disease association with raised permeability
• Inflammatory markers (CRP, fecal calprotectin), clinical context dependent
• Breath or stool testing if dysbiosis or SIBO is suspected — see the intestinal permeability testing comparison for how these methods differ
• Comprehensive stool testing if the picture is broader — the stool testing guide covers what those panels can and cannot tell you
• Diet and symptom logs tied to the test timing

A single test should not drive a 6-month supplement stack by itself.

The zonulin question

Lactulose-mannitol gives a direct functional permeability signal; zonulin is an indirect, upstream signal — a modulator of tight-junction function, not a measurement of leak itself (Fasano 2020). Commercial zonulin assays measure broadly and cross-react, and values vary with acute infection. If you use zonulin, treat it as a secondary clue, not the sole decision-maker. When the two disagree, the functional sugar test — done with a clean protocol — generally carries more weight. The full comparison lives in the permeability testing methods article and the broader leaky gut guide.

30-day action protocol (if results suggest barrier stress)

1. Remove obvious irritants: excess alcohol and an ultra-processed-heavy diet. Talk with your clinician about rationalizing frequent NSAID use — while the indomethacin trial above shows the effect is not universal, the question is worth asking rather than assuming.
2. Stabilize sleep and bowel rhythm. Circadian disruption and irregular eating both move barrier measures; this alone shifts markers more than most supplements.
3. Increase protein and whole-food micronutrient density, then use targeted support only after the baseline is stable. If you train hard, pre-exercise protein (whey showed an effect in RCT) is a low-risk, evidence-backed tweak.
4. Re-test only after consistent protocol adherence — typically 8 to 12 weeks. Random retesting adds noise, not information.

When to escalate quickly

Seek medical evaluation promptly for any of the following: blood in stool, persistent fever, significant weight loss, severe persistent abdominal pain, nighttime symptoms that wake you, or no response to a structured 4-to-8-week intervention. These are red-flag features, not permeability issues — the L/M ratio is irrelevant to the decision to get checked.

Key takeaways

• The lactulose-mannitol test estimates intestinal permeability; the L/M ratio is the more interpretable output because it corrects for individual absorption and excretion speed.
• One abnormal value is a signal, never a diagnosis — pattern plus symptom timeline plus confounder review is the minimum for interpretation.
• Classic confounders (NSAIDs, alcohol, recent infection, intense exercise) matter, but their effects vary: indomethacin did not raise permeability at all in healthy volunteers in a 2026 RCT.
• Low mannitol points at absorptive surface (screen for celiac), high lactulose points at paracellular leak; zonulin is an indirect clue with weaker assay validity.
• Re-test only after 8-12 weeks of a consistent protocol, and escalate red-flag symptoms to a clinician regardless of the ratio.

FAQ

Does an elevated lactulose-mannitol ratio prove I have "leaky gut syndrome"?

No. It shows increased paracellular permeability at the time of testing, which is a measurable finding associated with several conditions — celiac disease, IBS subtypes, acute infections, intense training — but "leaky gut syndrome" as a stand-alone diagnosis is not a recognized disease. Interpret the ratio alongside symptoms, celiac and inflammatory markers, and medication context, and treat it as one input to a clinical workup rather than an endpoint in itself.

Disclaimer

This article is educational only and is not medical advice. Consult a qualified clinician for diagnosis and treatment decisions tailored to your situation.